Skip to main content
. 2024 Feb 12;150(2):91. doi: 10.1007/s00432-024-05606-8

Fig. 3.

Fig. 3

Analysis of pathway enrichment and TME differences between two different clusters. A GSVA analysis between two different clusters; B Expression difference analysis of immune checkpoints in cluster 1 and cluster 2; C Expression difference analysis of HLA molecules in two HNSCC clusters (*p < 0.05; **p < 0.01; ***p < 0.001)